• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 VIP 受体诊断口腔癌:初步报告。

Diagnosis of Oral Cancers by Targeting VPAC Receptors: Preliminary Report.

机构信息

Department of Urology, JN Medical College, KLE Academy of Higher Education & Research (Deemed-to-be-University), JNMC Campus, Belagavi, India.

Department of Surgical-Oncology, JN Medical College, KLE Academy of Higher Education & Research (Deemed-to-be-University), JNMC Campus, Belagavi, India.

出版信息

Asian Pac J Cancer Prev. 2023 May 1;24(5):1711-1715. doi: 10.31557/APJCP.2023.24.5.1711.

DOI:10.31557/APJCP.2023.24.5.1711
PMID:37247292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10495900/
Abstract

INTRODUCTION

Oral cancer is a major health problem. The study of exfoliative cytology material helps in the differentiation of premalignant and malignant alterations of oral lesions. The objective of this study was to assess the feasibility of detecting oral cancer by targeting genomic VPAC (combined vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide) receptors expressed on malignant oral cancer cells.

PATIENTS & METHODS: All patients with suspected oral cavity cancers/lesions formed the study group. The samples from the oral cavity lesion or suspicious area were collected with a cytology brush. The harvested material was examined for malignant cells by 1. the standard PAP stain and 2. targeting the VPAC receptors on the cell surface using a fluorescent microscope. Similarly, malignant cells were identified from cells shed in oral gargles.

RESULTS

A total of 60 patients with oral lesions were included in the study. The histopathological diagnosis was squamous cell carcinoma in 30 of these. The VPAC receptor positivity both on the brush cytology staining as well oral gargle staining was more sensitive than the brush cytology PAP staining. The accuracy of the various techniques was as follows, brush cytology PAP staining at 86.67%, brush cytology VPAC staining at 91.67% and oral gargle VPAC staining at 95%.

CONCLUSIONS

This preliminary study validates our belief that malignant cells in the saliva can be identified by targeting the VPAC receptors. The test is simple, easy, non-invasive and reliable in the detection of oral cancers.

摘要

简介

口腔癌是一个主要的健康问题。研究脱落细胞学有助于区分口腔病变的癌前和恶性改变。本研究的目的是评估通过靶向表达在恶性口腔癌细胞上的基因组 VPAC(结合血管活性肠肽(VIP)和垂体腺苷酸环化酶激活肽)受体检测口腔癌的可行性。

患者和方法

所有疑似口腔癌/病变的患者均为研究组。使用细胞学刷采集口腔病变或可疑区域的样本。用 1. 标准 PAP 染色和 2. 荧光显微镜检测细胞表面的 VPAC 受体,对采集到的材料进行恶性细胞检查。同样,从口腔漱口液中脱落的细胞中鉴定恶性细胞。

结果

共有 60 名患有口腔病变的患者纳入研究。其中 30 名的组织病理学诊断为鳞状细胞癌。刷细胞学染色和口腔漱口液染色的 VPAC 受体阳性均比刷细胞学 PAP 染色更敏感。各种技术的准确性如下:刷细胞学 PAP 染色为 86.67%,刷细胞学 VPAC 染色为 91.67%,口腔漱口液 VPAC 染色为 95%。

结论

这项初步研究验证了我们的信念,即可以通过靶向 VPAC 受体来识别唾液中的恶性细胞。该测试简单、易用、非侵入性且可靠,可用于检测口腔癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9640/10495900/4597ccf175bd/APJCP-24-1711-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9640/10495900/4597ccf175bd/APJCP-24-1711-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9640/10495900/4597ccf175bd/APJCP-24-1711-g001.jpg

相似文献

1
Diagnosis of Oral Cancers by Targeting VPAC Receptors: Preliminary Report.靶向 VIP 受体诊断口腔癌:初步报告。
Asian Pac J Cancer Prev. 2023 May 1;24(5):1711-1715. doi: 10.31557/APJCP.2023.24.5.1711.
2
Localisation of VIP-binding sites exhibiting properties of VPAC receptors in chromaffin cells of rainbow trout (Oncorhynchus mykiss).虹鳟(Oncorhynchus mykiss)嗜铬细胞中表现出VPAC受体特性的血管活性肠肽结合位点的定位。
J Exp Biol. 2003 Jun;206(Pt 11):1917-27. doi: 10.1242/jeb.00350.
3
Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.垂体腺苷酸环化酶激活多肽、血管活性肠肽及其受体:在意大利壁蜥肾上腺分泌中的分布及作用
J Endocrinol. 2008 Feb;196(2):291-303. doi: 10.1677/JOE-07-0127.
4
Expression of functional PACAP/VIP receptors in human prostate cancer and healthy tissue.功能性促肾上腺皮质激素释放激素/血管活性肠肽受体在人前列腺癌组织和健康组织中的表达。
Peptides. 2003 Jun;24(6):893-902. doi: 10.1016/s0196-9781(03)00162-1.
5
Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.血管活性肠肽的苏氨酸11残基与VPAC2受体第一细胞外环中的酪氨酸184之间存在直接相互作用的证据。
Biochem J. 2003 Mar 15;370(Pt 3):1003-9. doi: 10.1042/BJ20020811.
6
Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.血管活性肠肽、垂体腺苷酸环化酶激活肽及其受体在人肾上腺中的表达与功能
J Clin Endocrinol Metab. 2002 Jun;87(6):2575-80. doi: 10.1210/jcem.87.6.8571.
7
Structural and functional identification of the pituitary adenylate cyclase-activating polypeptide receptor VPAC2 from the frog Rana tigrina rugulosa.虎纹蛙垂体腺苷酸环化酶激活多肽受体VPAC2的结构与功能鉴定
J Mol Endocrinol. 2001 Oct;27(2):229-38. doi: 10.1677/jme.0.0270229.
8
Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors.利用排尿样本并靶向基因组VPAC受体检测膀胱癌。
Indian J Urol. 2021 Oct-Dec;37(4):345-349. doi: 10.4103/iju.iju_132_21. Epub 2021 Oct 1.
9
Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.大鼠卵巢卵泡中不同垂体腺苷酸环化酶激活多肽/血管活性肠肽受体的特性与表达
J Endocrinol. 2006 Oct;191(1):287-99. doi: 10.1677/joe.1.06470.
10
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.血管活性肠肽和垂体腺苷酸环化酶激活肽受体的药理学和功能:国际药理学联合会评论 1。
Br J Pharmacol. 2012 May;166(1):4-17. doi: 10.1111/j.1476-5381.2012.01871.x.

引用本文的文献

1
VPAC receptor positivity in comparison with mp-MRI in the diagnosis of prostate cancer: A preliminary study.与磁共振多参数成像(mp-MRI)相比,VPAC受体阳性在前列腺癌诊断中的应用:一项初步研究。
BJUI Compass. 2025 Apr 22;6(4):e70006. doi: 10.1002/bco2.70006. eCollection 2025 Apr.

本文引用的文献

1
Oral cancer diagnosis and perspectives in India.印度口腔癌的诊断与展望
Sens Int. 2020;1:100046. doi: 10.1016/j.sintl.2020.100046. Epub 2020 Sep 24.
2
Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors.利用排尿样本并靶向基因组VPAC受体检测膀胱癌。
Indian J Urol. 2021 Oct-Dec;37(4):345-349. doi: 10.4103/iju.iju_132_21. Epub 2021 Oct 1.
3
Voided urine test to diagnose prostate cancer: Preliminary report.用于诊断前列腺癌的排尿尿液检测:初步报告。
Cytojournal. 2021 Oct 2;18:26. doi: 10.25259/Cytojournal_76_2020. eCollection 2021.
4
Effect of Hypofractionated, Palliative Radiotherapy on Quality of Life in Late-Stage Oral Cavity Cancer: A Prospective Clinical Trial.大分割姑息性放疗对晚期口腔癌患者生活质量的影响:一项前瞻性临床试验
Indian J Palliat Care. 2019 Jul-Sep;25(3):383-390. doi: 10.4103/IJPC.IJPC_115_18.
5
Liquid-based oral brush cytology in the diagnosis of oral leukoplakia using a modified Bethesda Cytology system.液体基口腔刷细胞学在改良巴氏细胞学系统中的口腔白斑病诊断中的应用。
J Oral Pathol Med. 2018 Oct;47(9):887-894. doi: 10.1111/jop.12759. Epub 2018 Jul 19.
6
The utility of oral brush cytology in the early detection of oral cancer and oral potentially malignant disorders: A systematic review.口腔刷细胞学在口腔癌和口腔潜在恶性疾病早期检测中的应用:系统评价。
J Oral Pathol Med. 2018 Feb;47(2):104-116. doi: 10.1111/jop.12660. Epub 2017 Dec 7.
7
Periodontal diseases and risk of oral cancer in Southern India: Results from the HeNCe Life study.印度南部的牙周疾病与口腔癌风险:HeNCe Life研究结果
Int J Cancer. 2016 Oct 1;139(7):1512-9. doi: 10.1002/ijc.30201. Epub 2016 Jun 17.
8
VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man.VPAC1靶向(64)Cu-TP3805正电子发射断层显像在前列腺癌中的应用:人体初步评估
Urology. 2016 Feb;88:111-8. doi: 10.1016/j.urology.2015.10.012. Epub 2015 Oct 28.
9
Cytomorphometric analysis of keratinized round cells in human oral carcinoma.人类口腔癌中角化圆形细胞的细胞形态计量分析
J Cytol. 2015 Apr-Jun;32(2):107-12. doi: 10.4103/0970-9371.160561.
10
VPAC1 receptors for imaging breast cancer: a feasibility study.用于乳腺癌成像的 VPAC1 受体:一项可行性研究。
J Nucl Med. 2013 Jul;54(7):1019-25. doi: 10.2967/jnumed.112.114876. Epub 2013 May 7.